Clinical Pathways: A Story of Continuous Improvement, Key Partnerships, and Improving Outcomes – Lessons Learned

Thursday, January 19, 2023, 8:00 AM - 9:00 AM, Marlo Thomas Center Lecture Hall, Memphis, TN

Presented by Leigh Anne Bakel, MD, MSc, Medical Director of Clinical Effectiveness, Director of the Clinical Pathways Program, Children’s Hospital Colorado; hosted by James Hoffman, PharmD, Senior Vice President of Quality and Safety, and Member, Department of Pharmacy and Pharmaceutical Sciences. 

This session will be held in person in the Marlo Thomas Center Lecture Hall; a Webex link will also be available.  

Webex Information: 
Join link: https://stjude.webex.com/stjude/j.php?MTID=m688d9ef8bcae4c0c332353edb1d7e3bf
Webinar number: 2458 834 0601
Webinar password: Grand1 (472631 from phones)
Call-in toll-free number (US/Canada): 1-877-668-4490

To add to your calendar, click the session title then choose "add to calendar." 

1. Determine key differences between Clinical Practice Guidelines, Pathways and Policy
2. Understand how process improvement accelerated the program
3. Gain knowledge of key partnerships that have contributed to our success
4. Appreciate our approach to improve outcomes
5. Learn from our experiences as you dive in!

St. Jude Children's Research Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

St. Jude Children’s Research Hospital designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1 Credits™ (1.00 hours), ABS CC (1.00 hours), Non-Physician Attendance (1.00 hours)

Mitigation of Relevant Financial Relationships

St Jude Children's Research Hospital adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (ie, companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Date	Empty Column	Title
		No activities are currently published for this month.
No upcoming dates have been setup.